Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058031) titled 'A single-center prospective observational study on cardiovascular complications associated with anthracycline-based anticancer agents, focusing on doxorubicin' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Yamaguchi University
Condition:
Condition - doxorubicin cardiomyopathy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to clarify the incidence of cardiomyopathy in patients administered doxorubicin.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 16
years-old
<=
Age-upper limit - Not applicable
Gender -...